Genmab Company
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
Technology:
Atrificial Vectors and Immune Cells
Headquarters:
Copenhagen, Hovedstaden, Denmark
Founded Date:
1999-01-01
Employees Number:
501-1000
Funding Status:
IPO
Investors Number:
6
Total Funding:
39500000
Estimated Revenue:
$100M to $500M
Last Funding Date:
2010-07-01
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership